A chimeric fusion protein containing transforming growth factor-α mediates gene transfer via binding to the EGF receptor

Gene Therapy

Volumn 5, Issue 4, 1998, Pages 521-530

  Fominaya, J ^a   Uherek, C ^a   Wels, W ^a,b  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

EGF receptor; Fusion protein; GAL4; Gene therapy; Non viral gene delivery; Pseudomonas exotoxin A; TGF

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; LUCIFERASE; POLYLYSINE; PSEUDOMONAS EXOTOXIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; DNA PROTEIN COMPLEX; ENDOSOME; GENE TARGETING; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE;

ANIMALIA; BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS EXOTOXIN;

EID: 0031891120     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300614     Document Type: Article

References (32)

1. Ledley FD. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6: 1129-1144.
2. Cooper MJ. Noninfectious gene transfer and expression systems for cancer gene therapy. Semin Oncol 1996; 23: 172-187.
3. Perales JC, Ferkol T, Molas M, Hanson RW. An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes. Eur J Biochem 1994; 226: 255-266.
4. Cristiano RJ, Curiel DT. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther 1996; 3: 49-57.
5. Chen SY, Zani C, Khouri Y, Marasco WA. Design of a genetic immunotoxin to eliminate toxin immunogenicity. Gene Therapy 1995; 2: 116-123.
6. Fominaya J, Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J Biol Chem 1996; 271: 10560-10568.
7. Paul RW et al. Gene transfer using a novel fusion protein, GAL4/invasin. Hum Gene Ther 1997; 8: 1253-1262.
8. Allured VS, Collier RJ, Carroll SF, McKay DB. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc Natl Acad Sci USA 1986; 83: 1320-1324.
9. Hwang J, Fitzgerald DJ, Adhya S, Pastan I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 1987; 48: 129-136.
10. Ogata M, Fryling CM, Pastan I, FitzGerald DJ. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. J Biol Chem 1992; 267: 25396-25401.
11. Gullick WJ Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991; 47: 87-98.
12. Chen J, Gamou S, Takayanagi A, Shimizu N. A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett 1994; 338: 167-169.
13. Cosset FL et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995; 69: 6314-6322.
14. Cristiano RJ, Roth JA. Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther 1996; 3: 4-10.
15. Seetharam S, Chaudhary VK, FitzGerald D, Pastan I. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J Biol Chem 1991; 266: 17376-17381.
16. Schmidt M, Vakalopoulou E, Schneider DW, Wels W. Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor. Br J Cancer 1997; 75: 1575-1584.
17. Bergeron JJ et al. Endosomes, receptor tyrosine kinase internalization and signal transduction. Biosci Rep 1995; 15: 411-118.
18. Felgner PL et al. Nomenclature for synthetic gene delivery systems Hum Gene Ther 1997; 8: 511-512 (editorial).
19. Kihara A, Pastan I. Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice. Cancer Res 1994; 54: 5154-5159.
20. Wels W et al. EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Int J Cancer 1995; 60: 137-144.
21. Zenke M et al. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells Proc Natl Acad Sci USA 1990; 87: 3655-3659.
22. Cotten M et al. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc Natl Acad Sci USA 1990; 87: 4033-4037.
23. Fritz JD, Herweijer H, Zhang G, Wolff JA. Gene transfer into mammalian cells using histone-condensed plasmid DNA. Hum Gene Ther 1996, 7: 1395-1404.
24. Wagner E, Curiel D, Cotten M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv Drug Del Rev 1994; 14: 113-135.
25. Wels W, Fominaya J. Peptides and fusion proteins as modular DNA earners In: Kabanov AV, Felgner P, Seymour LW (eds). Self-Assembling Complexes for Gene Delivery From Laboratory to Clinical Trial. Wiley: Chichester, 1998, pp 351-369.
26. Reddy CC, Wells A, Lauffenburger DA. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha J Cell Physiol 1996; 166: 512-522.
27. Novoa I, Cotten M, Carrasco L. Hybrid proteins between Pseudomonas aeruginosa exotoxin A and poliovirus 2Apro cleave p220 in HeLa cells. J Virol 1996; 70: 3319-3324.
28. Masui H, Castro L, Mendelsohn J. Consumption of EGF by A431 cells: evidence for receptor recycling. J Cell Biol 1993; 120: 85-93.
29. Gill GN, Lazar CS. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 1981; 293: 305-307.
30. Chin YE et al. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996; 272: 719-722.
31. Schmidt M, Wels W. Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha. Br J Cancer 1996; 74: 853-862.
32. Gullick WJ, Downward J, Waterfield MD. Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function. EMBO J 1985; 4: 2869-2877.